Marlys Koschinsky
#145,881
Most Influential Person Now
Canadian cardiovascular researcher
Marlys Koschinsky's AcademicInfluence.com Rankings
Marlys Koschinskymedical Degrees
Medical
#3535
World Rank
#4008
Historical Rank
Cardiology
#377
World Rank
#388
Historical Rank
Marlys Koschinskybiology Degrees
Biology
#13658
World Rank
#17213
Historical Rank
Biochemistry
#2447
World Rank
#2603
Historical Rank
Download Badge
Medical Biology
Why Is Marlys Koschinsky Influential?
(Suggest an Edit or Addition)According to Wikipedia, Marlys Laverne Koschinsky is a Canadian cardiovascular researcher. , she is the executive director at the University of Western Ontario's Robarts Research Institute. Koschinsky formally served as Dean of the Faculty of Science at the University of Windsor.
Marlys Koschinsky's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress. (2010) (410)
- Effect of the number of apolipoprotein(a) kringle 4 domains on immunochemical measurements of lipoprotein(a). (1995) (318)
- Oxidized Phospholipids on Lipoprotein(a) Elicit Arterial Wall Inflammation and an Inflammatory Monocyte Response in Humans (2016) (316)
- Report of the National Heart, Lung, and Blood Institute Workshop on Lipoprotein(a) and Cardiovascular Disease: recent advances and future directions. (2003) (286)
- NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis. (2018) (276)
- Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association. (2019) (221)
- Lipoprotein(a) as a risk factor for coronary artery disease. (1998) (190)
- Two Naturally Occurring Variants of TAFI (Thr-325 and Ile-325) Differ Substantially with Respect to Thermal Stability and Antifibrinolytic Activity of the Enzyme* (2002) (183)
- Autotaxin Derived From Lipoprotein(a) and Valve Interstitial Cells Promotes Inflammation and Mineralization of the Aortic Valve (2015) (176)
- Lipoprotein(a) Catabolism Is Regulated by Proprotein Convertase Subtilisin/Kexin Type 9 through the Low Density Lipoprotein Receptor* (2015) (175)
- Identification of the cysteine residue in apolipoprotein(a) that mediates extracellular coupling with apolipoprotein B-100. (1993) (174)
- The apolipoprotein(a) kringle IV repeats which differ from the major repeat kringle are present in variably-sized isoforms. (1993) (164)
- A Polymorphism in the Protease-Like Domain of Apolipoprotein(a) Is Associated With Severe Coronary Artery Disease (2007) (156)
- Reconstitution of lipoprotein(a) by infusion of human low density lipoprotein into transgenic mice expressing human apolipoprotein(a). (1992) (154)
- Lipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease? (2016) (153)
- Determinants of binding of oxidized phospholipids on apolipoprotein (a) and lipoprotein (a)1 (2013) (151)
- Apolipoprotein(a) size heterogeneity is related to variable number of repeat sequences in its mRNA. (1990) (145)
- Lipoprotein(a) and Oxidized Phospholipids Promote Valve Calcification in Patients With Aortic Stenosis (2019) (145)
- Lipoprotein(a) as a risk factor for atherosclerosis and thrombosis: mechanistic insights from animal models. (2004) (144)
- Lipoprotein(a) Levels and the Risk of Myocardial Infarction Among 7 Ethnic Groups (2019) (143)
- Lipoprotein(a) in atherosclerotic plaques recruits inflammatory cells through interaction with Mac‐1 integrin (2006) (142)
- Subclinical vitamin K deficiency in hemodialysis patients. (2007) (135)
- Structure-function relationships in apolipoprotein(a): insights into lipoprotein(a) assembly and pathogenicity (2004) (133)
- Apolipoprotein(a): expression and characterization of a recombinant form of the protein in mammalian cells. (1991) (127)
- Oxidized phospholipids as a unifying theory for lipoprotein(a) and cardiovascular disease (2019) (123)
- Inhibition of Plasminogen Activation by Lipoprotein(a) (2003) (114)
- Complete cDNA sequence of human preceruloplasmin. (1986) (113)
- Lipoprotein(a): more interesting than ever after 50 years (2012) (112)
- Biphasic transmittance waveform in the APTT coagulation assay is due to the formation of a Ca(++)-dependent complex of C-reactive protein with very-low-density lipoprotein and is a novel marker of impending disseminated intravascular coagulation. (2002) (111)
- Expression of adhesion molecules by Lp(a): a potential novel mechanism for its atherogenicity (1998) (109)
- Evaluation of lipoprotein(a) as a prothrombotic factor: progress from bench to bedside (2003) (108)
- Lipoprotein(a): a unique risk factor for cardiovascular disease. (2006) (105)
- Evaluation of Lp[a] and other independent risk factors for CHD in Asian Indians and their USA counterparts. (2001) (104)
- Curiouser and curiouser: recent advances in measurement of thrombin-activatable fibrinolysis inhibitor (TAFI) and in understanding its molecular genetics, gene regulation, and biological roles. (2007) (101)
- Characterization of the gene encoding human TAFI (thrombin-activable fibrinolysis inhibitor; plasma procarboxypeptidase B). (1999) (94)
- Human genes encoding prothrombin and ceruloplasmin map to 11p11–q12 and 3q21–24, respectively (1987) (89)
- Apolipoprotein(a) and plasminogen interactions with fibrin: a study with recombinant apolipoprotein(a) and isolated plasminogen fragments. (1992) (85)
- Defensin promotes the binding of lipoprotein(a) to vascular matrix. (1999) (79)
- Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement (2022) (75)
- Lipoprotein(a) assembly. Quantitative assessment of the role of apo(a) kringle IV types 2-10 in particle formation. (1996) (74)
- Mechanisms of lipoprotein(a) pathogenicity: prothrombotic, proatherosclerotic, or both? (2012) (73)
- Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association. (2021) (68)
- Lipoprotein(a) concentration and apolipoprotein(a) size: A synergistic role in advanced atherosclerosis? (1999) (68)
- Apolipoprotein(a) enhances platelet responses to the thrombin receptor-activating peptide SFLLRN. (1998) (67)
- OxLDL-derived lysophosphatidic acid promotes the progression of aortic valve stenosis through a LPAR1-RhoA–NF-&kgr;B pathway (2017) (66)
- Mechanistic insights into Lp(a)-induced IL-8 expression: a role for oxidized phospholipid modification of apo(a)[S] (2015) (65)
- Lipoprotein(a) and coronary heart disease risk (1999) (63)
- A novel, possibly functional, single nucleotide polymorphism in the coding region of the thrombin-activatable fibrinolysis inhibitor (TAFI) gene is also associated with TAFI levels. (2001) (63)
- Lipoprotein(a) Is Associated Differentially With Carotid Stenosis, Occlusion, and Total Plaque Area (2008) (62)
- Oxidized phospholipids are present on plasminogen, affect fibrinolysis, and increase following acute myocardial infarction. (2012) (61)
- Apolipoprotein(a) attenuates endogenous fibrinolysis in the rabbit jugular vein thrombosis model in vivo. (1997) (59)
- Acute Phase Mediators Modulate Thrombin-activable Fibrinolysis Inhibitor (TAFI) Gene Expression in HepG2 Cells* (2003) (59)
- The renaissance of lipoprotein(a): Brave new world for preventive cardiology? (2017) (58)
- Atherogenic Lipoprotein(a) Increases Vascular Glycolysis, Thereby Facilitating Inflammation and Leukocyte Extravasation (2020) (58)
- The Apolipoprotein(a) Component of Lipoprotein(a) Stimulates Actin Stress Fiber Formation and Loss of Cell-Cell Contact in Cultured Endothelial Cells* (2004) (56)
- Molecular studies of ceruloplasmin deficiency in Wilson's disease. (1987) (55)
- Sequences within apolipoprotein(a) kringle IV types 6-8 bind directly to low-density lipoprotein and mediate noncovalent association of apolipoprotein(a) with apolipoprotein B-100. (1998) (54)
- Antifibrinolytic effect of recombinant apolipoprotein(a) in vitro is primarily due to attenuation of tPA-mediated Glu-plasminogen activation. (1995) (53)
- The solution phase interaction between apolipoprotein(a) and plasminogen inhibits the binding of plasminogen to a plasmin-modified fibrinogen surface. (1997) (53)
- Apolipoprotein(a), through Its Strong Lysine-binding Site in KIV10, Mediates Increased Endothelial Cell Contraction and Permeability via a Rho/Rho Kinase/MYPT1-dependent Pathway* (2008) (51)
- Apolipoprotein(a) inhibits the conversion of Glu‐plasminogen to Lys‐plasminogen: a novel mechanism for lipoprotein(a)‐mediated inhibition of plasminogen activation (2008) (51)
- Effect of single nucleotide polymorphisms on expression of the gene encoding thrombin-activatable fibrinolysis inhibitor: a functional analysis. (2008) (50)
- Binding of recombinant apolipoprotein(a) to extracellular matrix proteins. (1994) (50)
- Lipoprotein(a) and atherosclerosis: New perspectives on the mechanism of action of an enigmatic lipoprotein (2005) (49)
- A critical evaluation of the role of Lp(a) in cardiovascular disease: can Lp(a) be useful in risk assessment? (2002) (48)
- Inhibition of plasminogen activation by apo(a): role of carboxyl-terminal lysines and identification of inhibitory domains in apo(a)[S] (2014) (46)
- Identification of a Critical Lysine Residue in Apolipoprotein B-100 That Mediates Noncovalent Interaction with Apolipoprotein(a)* (2001) (45)
- Quantitative Evaluation of the Contribution of Weak Lysine-binding Sites Present within Apolipoprotein(a) Kringle IV Types 6–8 to Lipoprotein(a) Assembly* (2004) (41)
- Lipoprotein(a): structural implications for pathophysiology (1997) (41)
- The relationship between lipoprotein(a) and the complications of diabetes mellitus (2003) (40)
- Novel insights into Lp(a) physiology and pathogenicity: more questions than answers? (2006) (40)
- Speckle spectro-polarimetry of solar magnetic structures (2001) (39)
- Interaction of a recombinant form of apolipoprotein[a] with human fibroblasts and with the human hepatoma cell line HepG2. (1996) (39)
- Thrombin activable fibrinolysis inhibitor (TAFI): molecular genetics of an emerging potential risk factor for thrombotic disorders. (2001) (38)
- Isolation, quantitation, and characterization of a stable complex formed by Lp[a] binding to triglyceride-rich lipoproteins. (2001) (38)
- Role of mRNA transcript stability in modulation of expression of the gene encoding thrombin activable fibrinolysis inhibitor (2004) (36)
- Lipoprotein(a) and the link between atherosclerosis and thrombosis. (2004) (36)
- Effects of lipoprotein(a) on the binding of plasminogen to fibrin and its activation by fibrin-bound tissue-type plasminogen activator. (1994) (36)
- Evidence mounts for a role of the kidney in lipoprotein(a) catabolism. (2007) (35)
- Update on Lipoprotein(a) as a Cardiovascular Risk Factor and Mediator (2013) (35)
- Roles of the low density lipoprotein receptor and related receptors in inhibition of lipoprotein(a) internalization by proprotein convertase subtilisin/kexin type 9 (2017) (35)
- Plasminogen promotes cholesterol efflux by the ABCA1 pathway. (2017) (34)
- Long Noncoding RNA MIAT Controls Advanced Atherosclerotic Lesion Formation and Plaque Destabilization (2021) (33)
- New Frontiers in Lp(a)-Targeted Therapies. (2019) (33)
- Expression and characterization of apolipoprotein(a) kringle IV types 1, 2 and 10 in mammalian cells. (1994) (33)
- The I4399M variant of apolipoprotein(a) is associated with increased oxidized phospholipids on apolipoprotein B-100 particles. (2010) (32)
- High resolution 2D-spectroscopy of granular dynamics (2001) (31)
- The Binding Activity of the Macrophage Lipoprotein(a)/Apolipoprotein(a) Receptor Is Induced by Cholesterol via a Post-translational Mechanism and Recognizes Distinct Kringle Domains on Apolipoprotein(a)* (1996) (31)
- Catalysis of covalent Lp(a) assembly: evidence for an extracellular enzyme activity that enhances disulfide bond formation. (2006) (30)
- Lipoprotein(a): an important cardiovascular risk factor and a clinical conundrum. (2014) (30)
- A Role for CCAAT/Enhancer-binding Protein in Hepatic Expression of Thrombin-activable Fibrinolysis Inhibitor* (2002) (28)
- Apolipoprotein(a) stimulates nuclear translocation of β-catenin: a novel pathogenic mechanism for lipoprotein(a) (2013) (28)
- Stimulation of Vascular Smooth Muscle Cell Proliferation and Migration by Apolipoprotein(a) Is Dependent on Inhibition of Transforming Growth Factor-β Activation and on the Presence of Kringle IV Type 9* (2004) (28)
- Apolipoprotein(a) Phenotype and Lipoprotein(a) Level Predict Peritoneal Dialysis Patient Mortality (2002) (27)
- The structure of lipoprotein(a) and ligand-induced conformational changes. (2001) (27)
- Lipoprotein(a) and secondary prevention of atherothrombotic events: A critical appraisal. (2018) (27)
- Apolipoprotein(a) Inhibits In Vitro Tube Formation in Endothelial Cells: Identification of Roles for Kringle V and the Plasminogen Activation System (2013) (27)
- Apolipoprotein(a) stimulates vascular endothelial cell growth and migration and signals through integrin alphaVbeta3. (2009) (26)
- Activation of liver X receptor attenuates lysophosphatidylcholine‐induced IL‐8 expression in endothelial cells via the NF‐κB pathway and SUMOylation (2016) (26)
- Development of an LC-MS/MS Proposed Candidate Reference Method for the Standardization of Analytical Methods to Measure Lipoprotein(a). (2021) (25)
- Comparative analyses of the lysine binding site properties of apolipoprotein(a) kringle IV types 7 and 10. (2002) (25)
- Identification of sequences in apolipoprotein(a) that maintain its closed conformation: a novel role for apo(a) isoform size in determining the efficiency of covalent Lp(a) formation. (2004) (24)
- Pathobiology of Lp(a) in calcific aortic valve disease (2017) (24)
- Carboxyl‐terminal truncation of apolipoproteinB‐100 inhibits lipoprotein(a) particle formation (1994) (23)
- High‐resolution crystal structure of apolipoprotein(a) kringle IV type 7: Insights into ligand binding (2001) (23)
- Lipoprotein(a) as a therapeutic target in cardiovascular disease (2014) (22)
- Identification of human thrombin-activatable fibrinolysis inhibitor in vascular and inflammatory cells (2011) (22)
- Isolation and characterization of a processed gene for human ceruloplasmin. (1987) (22)
- Analysis of the mechanism of lipoprotein(a) assembly (1997) (21)
- A Ligand-induced Conformational Change in Apolipoprotein(a) Enhances Covalent Lp(a) Formation* (2003) (21)
- Potent reduction of plasma lipoprotein (a) with an antisense oligonucleotide in human subjects does not affect ex vivo fibrinolysis[S] (2019) (20)
- Apolipoprotein(a) acts as a chemorepellent to human vascular smooth muscle cells via integrin αVβ3 and RhoA/ROCK-mediated mechanisms☆ (2013) (20)
- An Apolipoprotein(a) Peptide Delays Chylomicron Remnant Clearance and Increases Plasma Remnant Lipoproteins and Atherosclerosis In Vivo (2005) (20)
- Inhibition of Plasminogen Activation by Lipoprotein(a): Critical Domains in Apolipoprotein(a) and Mechanism of Inhibition on Fibrin and Degraded Fibrin Surfaces (2003) (17)
- The apolipoprotein(a) component of lipoprotein(a) mediates binding to laminin: contribution to selective retention of lipoprotein(a) in atherosclerotic lesions. (2005) (17)
- Association of a single nucleotide polymorphism in CPB2 encoding the thrombin-activable fibrinolysis inhibitor (TAF1) with blood pressure. (2001) (17)
- Molecular analysis of the human thrombin‐activatable fibrinolysis inhibitor gene promoter (2007) (17)
- Characterization of the basis of lipoprotein [a] lysine-binding heterogeneity. (2000) (16)
- Sequences within the amino terminus of ApoB100 mediate its noncovalent association with apo(a). (1998) (16)
- Lipoprotein(a) in clinical practice: New perspectives from basic and translational science (2018) (15)
- Definition of the structural elements in plasminogen required for high-affinity binding to apolipoprotein(a): a study utilizing surface plasmon resonance. (2004) (15)
- Expert position statements: comparison of recommendations for the care of adults and youth with elevated lipoprotein(a). (2021) (15)
- Carboxyl-terminal truncation of apolipoproteinB-100 inhibits lipoprotein(a) particle formation. (1994) (14)
- Antifibrinolytic effect of single apo(a) kringle domains: relationship to fibrinogen binding. (2001) (13)
- Expression of apolipoprotein(a) kringle IV type 9 in Escherichia coli: demonstration of a specific interaction between kringle IV type 9 and apolipoproteinB-100. (1998) (13)
- Baboon lipoprotein(a) binds very weakly to lysine-agarose and fibrin despite the presence of a strong lysine-binding site in apolipoprotein(a) kringle IV type 10. (2005) (13)
- Characterization of the interaction of recombinant apolipoprotein(a) with modified fibrinogen surfaces and fibrin clots. (2000) (12)
- Pathophysiology and Risk of Atrial Fibrillation Detected after Ischemic Stroke (PARADISE): A Translational, Integrated, and Transdisciplinary Approach. (2017) (12)
- Screening for and Management of Elevated Lp(a) (2013) (12)
- Pro-inflammatory cytokines reduce human TAFI expression via tristetraprolin-mediated mRNA destabilisation and decreased binding of HuR (2015) (12)
- Interaction of Autotaxin With Lipoprotein(a) in Patients With Calcific Aortic Valve Stenosis (2020) (11)
- Growth and development of Hymenolepis nana in mice maintained at different environmental temperatures. (1986) (10)
- Oxidized phospholipid modification of lipoprotein(a): Epidemiology, biochemistry and pathophysiology. (2022) (10)
- The journey towards understanding lipoprotein(a) and cardiovascular disease risk: are we there yet? (2018) (10)
- Plasminogen binds to plasmin-modulated factor Xa by Ca2+- and C-terminal lysine-dependent and -independent interactions (2006) (10)
- Regulation of the mouse gene encoding TAFI by TNFα: role of NFκB binding site. (2012) (10)
- JCL roundtable-Lipoprotein(a): The emerging risk factor. (2018) (10)
- Analysis of structure--function relationships in human apolipoprotein(a). (1994) (10)
- Characterization of the I4399M variant of apolipoprotein(a): implications for altered prothrombotic properties of lipoprotein(a) (2016) (10)
- Apolipoprotein(a) inhibits hepatitis C virus entry through interaction with infectious particles (2017) (9)
- Lipoprotein-complexed C-reactive protein and the biphasic transmittance waveform in critically ill patients. (2002) (9)
- CHAPTER 11 – Lipoprotein(a) (2009) (9)
- Regulation of the gene encoding human thrombin-activatable fibrinolysis inhibitor by estrogen and progesterone (2013) (9)
- The mRNA encoding TAFI is alternatively spliced in different cell types and produces intracellular forms of the protein lacking TAFIa activity (2013) (9)
- Lipoprotein(a): Expanding Our Knowledge of Aortic Valve Narrowing. (2020) (8)
- Apolipoprotein(a) inhibits the conversion of Glu-plasminogen to Lys-plasminogen on the surface of vascular endothelial and smooth muscle cells. (2018) (8)
- Increased Lipoprotein ( a ) levels are not a steady prothrombotic defect (2001) (7)
- Global think tank on the clinical considerations and management of lipoprotein(a): The top questions and answers regarding what clinicians need to know. (2022) (7)
- Nuclear magnetic resonance (NMR) solution structure, dynamics, and binding properties of the kringle IV type 8 module of apolipoprotein(a). (2007) (7)
- Lipoprotein Proteomics and Aortic Valve Transcriptomics Identify Biological Pathways Linking Lipoprotein(a) Levels to Aortic Stenosis (2021) (7)
- HEIGHT VARIATION OF THE SOLAR GRANULATION (1999) (7)
- A Comparative Analysis of the Lipoprotein(a) and Low-Density Lipoprotein Proteomic Profiles Combining Mass Spectrometry and Mendelian Randomization (2020) (7)
- On the use of Bowen compensators for polarimetry (1996) (6)
- A role for apolipoprotein(a) in protection of the low-density lipoprotein component of lipoprotein(a) from copper-mediated oxidation. (2003) (6)
- Granular velocities of the Sun from speckle interferometry (2000) (5)
- Generation and characterization of LPA-KIV9, a murine monoclonal antibody binding a single site on apolipoprotein (a) (2020) (5)
- Identification of tristetraprolin as a factor that modulates the stability of the TAFI transcript through binding to the 3′‐untranslated region (2012) (5)
- The complete cDNA sequence encoding plasminogen from the European hedgehog (Erinaceus europaeus). (1996) (5)
- Effect of low-density lipoprotein buoyant density and cholesterol content on the formation of lipoprotein(a) particles (2001) (5)
- Proprotein convertase subtilisin/kexin type 9 inhibitors and lipoprotein(a)-mediated risk of atherosclerotic cardiovascular disease: more than meets the eye? (2019) (5)
- The long journey of lipoprotein(a) from cardiovascular curiosity to therapeutic target. (2022) (4)
- Evaluating The Roles Of PCSK9 And Specific Receptors In Lipoprotein(A) Catabolism (2016) (4)
- Lipoprotein[a] is not present in the plasma of patients with some peroxisomal disorders. (1997) (4)
- Lipoprotein(a) (1996) (4)
- Apo(a) and ApoB Interact Noncovalently Within Hepatocytes: Implications for Regulation of Lp(a) Levels by Modulation of ApoB Secretion (2022) (4)
- Structure of the genes encoding proteins involved in blood clotting (1988) (4)
- Localization of the processed gene for human ceruloplasmin to chromosome region 8q21.13----q23.1 by in situ hybridization. (1988) (4)
- Inhibition of pericellular plasminogen activation by apolipoprotein(a): Roles of urokinase plasminogen activator receptor and integrins αMβ2 and αVβ3. (2018) (4)
- Lipoprotein(a) as an Emerging Risk Factor for Atherothrombosis (2007) (3)
- PCSK9 deficiency results in a specific shedding of excess LDLR in female mice only: Role of hepatic cholesterol. (2022) (3)
- Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association. (2022) (3)
- OXIDIZED PHOSPHOLIPIDS ON APOLIPOPROTEIN(A) ARE ONLY PRESENT ON HUMAN LP(A): IMPLICATIONS FOR UNDERSTANDING LP(A) ATHEROGENICS (2013) (3)
- Sortilin enhances secretion of apolipoprotein(a) through effects on apolipoprotein B secretion and promotes uptake of lipoprotein(a) (2022) (2)
- AUTOTAXIN ENHANCES AORTIC VALVE MINERALIZATION THROUGH A NF-κB / IL-6 / BMP-2 DEPENDENT INFLAMMATORY PATHWAY (2015) (2)
- Progressive kidney disease in three sisters with elevated lipoprotein(a). (2008) (2)
- Abstract 2: Elucidation of the Mechanism of Apolipoprotein(a)/Lipoprotein(a)-Induced Interleukin 8 Gene Expression: Insight into Potential Receptors and Signaling Pathways and the Role of Oxidized Phospholipids (2014) (2)
- Apolipoprotein(a)-Dependent Inhibition of Pericellular Plasminogen Activation Is Mediated by Specific Cellular Receptors (2011) (2)
- Apolipoprotein(a) Phenotype, Albumin Clearance, and Plasma Levels of Lipoprotein(a) in Peritoneal Dialysis (2001) (2)
- Ground-based Observation with High Spatial and Spectral Resolution (1998) (2)
- Activated protein C resistance and low molecular weight lipoprotein (a): dual pathogens for atherothrombosis? (2005) (2)
- Complete cDNA sequence of human preceruloplasmin ( copper-binding protein / oligonucleotides / amino acid sequence homology / gene evolution ) (1)
- Unmet Needs in Understanding Lipoprotein(a) Pathophysiology: NHLBI Working Group Recommendations to Reduce Risk of Cardiovascular Disease and Aortic Stenosis (2018) (1)
- Structure, Function and Regulation of Lipoprotein(a) (1996) (1)
- Genetics to the Rescue: Sophisticated Approaches Provide Critical Insights Into the Determination of Lp(a) Levels. (2021) (1)
- Oxidized phospholipids on lipoprotein(a) induce epigenetic reprogramming and an increased pro-atherogenic response in human monocytes. (2017) (1)
- Understanding the ins and outs of lipoprotein (a) metabolism (2022) (1)
- Abstract 20583: Sortilin Promotes Secretion of Apolipoprotein(a) by Hepatic Cells (2016) (1)
- Therapeutic Lowering of Lipoprotein(a): A Role for Pharmacogenetics? (2018) (1)
- Apolipoprotein(a) inhibits hepatitis C virus entry (2016) (1)
- Identification of a Novel Apolipoprotein(a)-related Protein from the European Hedgehog ( Erinaceus europaeus ) (2003) (1)
- The effect of a 17-kringle recombinant form of apolipoprotein(a) on in vitro fibrin clot lysis (1994) (0)
- Abstract P110: Molecular Modeling Of Apolipoprotein(a): Insight Into The Orientation Of Key Functional Domains Mediating Lipoprotein(a) Assembly And Ligand Binding (2021) (0)
- Lipoprotein (a): Principles from Bench to Bedside (2020) (0)
- Interaction of Autotaxin with Apolipoprotein(a) in Humans (2018) (0)
- Lp(A)-Dependent Inflammasome Activation As A Driver Of Its Atherogenicity (2019) (0)
- PT073 Lipoprotein(A) and Risk of Myocardial Infarction in Major Ethnic Groups (2016) (0)
- Angelo Scanu Memorial (2018) (0)
- ID: 288 Lipoprotein(a) Isoform Size Heterogeneity: Functional Implications for Plasminogen Activation (2006) (0)
- Minimum sequences in apolipoprotein(a) required for lipoprotein(a) assembly (1994) (0)
- Characterization of the human ceruloplasmin cDNA and gene (1988) (0)
- Exon Skipping and Alternative Splicing of CPB2 mRNA in Multiple Cell Types Results in Variants of TAFI That Are Inactive and Not Secretable (2011) (0)
- Effects of Lipoprotein(a) on Plasma Clot Formation and Lysis in vitro (2018) (0)
- Abstract 410: Lipoprotein(a) And Apolipoprotein(a) Inhibit Lysis Of Human Thrombi Formed From Whole Blood Under Conditions Of Flow (2022) (0)
- 2.P.128 Recombinant apolipoprotein(a) and lipoprotein(a) enhance platelet responses to a thrombin receptor-activating peptide (1997) (0)
- Abstract 115: Direct Evidence for the Intracellular Non-covalent Interaction of Apolipoprotein(a) and ApolipoproteinB100 During Lipoprotein(a) Biosynthesis (2020) (0)
- Edinburgh Explorer Lipoprotein(a) and Oxidized Phospholipids Promote Valve Calcification in Patients With Aortic Stenosis (2019) (0)
- From the EAS:* frequent questions and responses on the 2022 lipoprotein(a) consensus statement of the European Atherosclerosis Society (2023) (0)
- Abstract MP47: Assessment Of Atherosclerosis In A Novel Transgenic Mouse Expressing Pathogenic Levels Of Human Lipoprotein(a) (2021) (0)
- Regulation of Human Thrombin-Activable Fibrinolysis Inhibitor Gene Expression in Megakaryocyte-Like (Dami) and Monocyte/Macrphage- Like (THP-1) Cell Lines (2008) (0)
- Development of LC-MS/MS reference method for the quantification of lipoprotein(a) (2021) (0)
- analysis encoding thrombin-activatable fibrinolysis inhibitor: a functional Effect of single nucleotide polymorphisms on expression of the gene (2010) (0)
- Identification of the domains in apo(a) which mediate its interaction with fibrin (1994) (0)
- Surface LDLR is a major receptor for lipoprotein(a) clearance in male mice lacking PCSK9. (2023) (0)
- 02 - A COMPARATIVE PROTEOMIC ANALYSIS OF LIPOPROTEIN(A) AND LOW-DENSITY LIPOPROTEINS (2019) (0)
- Contents, Vol. 47, 1988 (1988) (0)
- Contributors (2022) (0)
- BAS/BSCR29 Apolipoprotein(a) impairs adaptive remodelling in human saphenous vein endothelial and smooth muscle cells (2010) (0)
- Abstract 437: Lipoprotein(a) Internalization in HepG2 Cells is Regulated by Proprotein Convertase Subtilisin Kexin Type 9 Through the Low-Density Lipoprotein Receptor (2014) (0)
- Reduction Of Plasma Lipoprotein(A) With Antisense Oligonucleotides In Human Subjects Does Not Affect Fibrinolysis (2019) (0)
- LPA disruption with AAV-CRISPR potently lowers plasma apo(a) in transgenic mouse model: A proof-of-concept study (2022) (0)
- Residual inflammatory risk increases endothelial metabolism, thereby facilitating sustained vascular inflammation and leukocyte extravasation (2021) (0)
- In Memoriam: Angelo Scanu (1924-2018)1 (2018) (0)
- PLASMINOGEN, OXIDIZED PHOSPHOLIPIDS AND ATHEROTHROMBOSIS (2011) (0)
- Regulation of the Gene Encoding Human Thrombin-Activable Fibrinolysis Inhibitor by Female Sex Steroids (2008) (0)
- The formation of a Ca2+-dependent complex of C-reactive protein and very low density lipoprotein causes the biphasic transmittance waveform (2001) (0)
- LDLR Activity and Subcellular Distribution is Sensitive to Estrogen in Mice Lacking PCSK9 (2018) (0)
- A Comparative Proteomic Analysis Of Lipoprotein(A) And Low-Density Lipoproteins (2019) (0)
- Significance of the Met → Thr mutation in apolipoprotein(a) kringle IV type 10 (1994) (0)
- NMR Solution Structure, Dynamics and Binding Properties of the Kringle IV Type 8 module of apolipoprotein(a) (2006) (0)
- Intracoronary Stents: Medical Devices at the Interface of Biology and Electrochemistry (2013) (0)
- 2d-Spectroscopy with the Image Scanner of the Gregory-Coudé-Telescope on Tenerife (1997) (0)
- LIPOPROTEIN ( A ) : ON THE CUTTING EDGE OF OCCAM ’ S RAZOR (2004) (0)
- Spectral and Spatial High Resolution Observations of the Sun with Image Reconstruction and Deconvolution Methods (1999) (0)
- Distribution of Apolipoprotein(a)-Containing Species in Human Plasma Assessed by Fast Protein Liquid Chromatography (2019) (0)
- Abstract 530: Identification Of The Specific Residue In Apolipoprotein(a) Responsible For Mediating Covalent Attachment Of Oxidized Phospholipids (2022) (0)
- Speckle Spectro-Polarimetry of Small-Scale Magnetic Structures (2001) (0)
- Corrigendum to Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association [Journal of Clinical Lipidology Volume 13, Issue 3, May–June 2019, Pages 374-392] (2022) (0)
- Solar Observation with High Spatial and Spectral Resolution (1999) (0)
- Apo(a) Expression in Transgenic Mice a (1994) (0)
- Lipoprotein(a) Transports Diverse Host and Non-Host Small RNAs in Circulation (2018) (0)
- Solar Observation with high spectral resolution and image restoration. (1999) (0)
- Lp(a) induces inflammasome activation in human macrophages (2021) (0)
- The effect of hormone replacement therapy on lipoprotein(a) levels in postmenopausal women (1999) (0)
- Subject Index Vol. 47, 1988 (1988) (0)
- Abstract 215: Enhanced Atherosclerosis, Inflammation And Oxidized Phospholipid Reactivity In Female Transgenic Mice Expressing Human Lp(a) (2022) (0)
- Abstract 18: Apo(a) Isoform Size Is Associated with Myocardial Infarction in a Study of an Admixed Population from the Central Valley of Costa Rica (2012) (0)
This paper list is powered by the following services:
Other Resources About Marlys Koschinsky
What Schools Are Affiliated With Marlys Koschinsky?
Marlys Koschinsky is affiliated with the following schools:
